Replimune to Present at Two Upcoming Investor Conferences

WOBURN, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that members from the Replimune management team will host investor meetings at the following two conferences: 2024 Wedbush PacGrow Healthcare Conference Date: Tuesday, August 13, 2024 Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer tre ...